Main topics
- Rare/genetic diseases
- Experimental models
- Therapies for genetic diseases
Keynote & Featured lectures
-
TBA
Invited speakers
- TBA
- TBA
- TBA
- TBA
Dear Colleagues,
It is my great pleasure to invite you to the 8th CCP Phenogenomics Conference, which will take place in September 2026.
As in previous years, our scientific program remains firmly dedicated to the critical theme of “Rare/genetic diseases, experimental models and therapies for genetic diseases.” This enduring focus reflects the CCP’s core mission to bridge the gap between deciphering gene function and developing clinical applications. As technologies evolve, this annual gathering becomes increasingly vital for sharing the latest breakthroughs in model generation and therapeutic strategies.
We believe the conference will once again serve as an excellent platform to foster networking and dynamic interactions. It provides a unique opportunity for the scientific community, from basic researchers to industry partners, to connect with CCP experts and shape the future of translational medicine together.
We eagerly anticipate your participation, whether in person in Prague or via our virtual platform.
Yours sincerely,
Radislav Sedláček
Director of the Czech Centre for Phenogenomics
Institute of Molecular Genetics of the Czech Academy of Sciences
Czech Centre for Phenogenomics (CCP)
The Czech Centre for Phenogenomics marks its tenth anniversary as a leading national and European infrastructure for disease modelling and phenotyping, having grown from a small transgenic unit into one of Europe’s most comprehensive centres.
With over 140 experts and an integrated pipeline spanning genome editing, high-throughput phenotyping, and preclinical testing, CCP serves as a “one-stop shop” for academic and industrial users and plays a key role in international initiatives such as INFRAFRONTIER and the International Mouse Phenotyping Consortium. By combining state-of-the-art in vivo technologies with forward-looking investments in rare disease research, gene therapy, advanced in vitro models, and AI-driven phenotyping, CCP stands as a mature, internationally recognised hub committed to innovation and scientific excellence for the benefit of society.
The conference is organized within the scope of the research programme “Towards Precision Medicine and Gene Therapy” of the Strategy AV21 supported by the Czech Academy of Sciences.
The conference covers topics related to the research focus of the National centre for new methods of diagnosis, monitoring, treatment and prevention of genetic diseases This project (ID: TN02000132, 2023 – 2026) is co-funded with state aid by the Technology Agency of the Czech Republic in the framework of the Programme National Centres of Competence.